Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Cancers 2010, 2(4), 1830-1837; doi:10.3390/cancers2041830
Review

Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology

Received: 21 October 2010; Accepted: 29 October 2010 / Published: 2 November 2010
(This article belongs to the Special Issue Pancreatic Cancer)
View Full-Text   |   Download PDF [147 KB, uploaded 2 November 2010]
Abstract: Pancreatic cancer is the fourth most common cause of cancer-related mortality in the United States. Biomarkers are needed to detect this cancer early during the disease development and for screening populations to identify those who are at risk. In cancer, “biomarker” refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker might be either a molecule secreted by a tumor or it can be a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. A number of potential biomarkers have been identified for pancreatic cancer. These markers can be assayed in non-invasively collected biofluids. These biomarkers need analytical and clinical validation so that they can be used for the purpose of screening and diagnosing pancreatic cancer and determining disease prognosis. In this article, the latest developments in pancreatic cancer biomarkers are discussed.
Keywords: biomarker; cancer; diagnosis; epidemiology; epigenetics; glycans; methylation index; pancreas; prognosis; sensitivity; specificity; survival; treatment biomarker; cancer; diagnosis; epidemiology; epigenetics; glycans; methylation index; pancreas; prognosis; sensitivity; specificity; survival; treatment
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Verma, M. Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology. Cancers 2010, 2, 1830-1837.

AMA Style

Verma M. Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology. Cancers. 2010; 2(4):1830-1837.

Chicago/Turabian Style

Verma, Mukesh. 2010. "Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology." Cancers 2, no. 4: 1830-1837.



Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert